BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28424683)

  • 1. Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.
    Kaur K; Cook J; Park SH; Topchyan P; Kozlowska A; Ohanian N; Fang C; Nishimura I; Jewett A
    Front Immunol; 2017; 8():297. PubMed ID: 28424683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells.
    Kaur K; Ko MW; Ohanian N; Cook J; Jewett A
    Sci Rep; 2020 Nov; 10(1):20363. PubMed ID: 33230147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.
    Kaur K; Jewett A
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice.
    Kaur K; Kozlowska AK; Topchyan P; Ko MW; Ohanian N; Chiang J; Cook J; Maung PO; Park SH; Cacalano N; Fang C; Jewett A
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878338
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions.
    Kaur K; Jewett A
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors
    Kaur K; Topchyan P; Kozlowska AK; Ohanian N; Chiang J; Maung PO; Park SH; Ko MW; Fang C; Nishimura I; Jewett A
    Oncoimmunology; 2018; 7(5):e1426518. PubMed ID: 29721395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
    Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
    Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice.
    Kaur K; Chang HH; Cook J; Eibl G; Jewett A
    Front Immunol; 2017; 8():1606. PubMed ID: 29255459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and Differences between Osteoclast-Mediated Functional Activation of NK, CD3+ T, and γδ T Cells from Humans, Humanized-BLT Mice, and WT Mice.
    Kaur K; Jewett A
    Crit Rev Immunol; 2024; 44(2):61-75. PubMed ID: 38305337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice.
    Kaur K; Chang HH; Topchyan P; Cook JM; Barkhordarian A; Eibl G; Jewett A
    Front Immunol; 2018; 9():1229. PubMed ID: 29977235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
    Masuyama J; Murakami T; Iwamoto S; Fujita S
    Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies to target cancer stem cells by NK cells; studies in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Front Biosci (Landmark Ed); 2017 Jan; 22(2):370-384. PubMed ID: 27814619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
    Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
    Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of dendritic cells on expansion and function of autologous natural killer cells in vitro].
    Li J; Zhao CT; Meng DM; Sun PP; Yang J; Chen B; Zhao XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):898-902. PubMed ID: 18718086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
    Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice.
    Kaur K; Chen PC; Ko MW; Mei A; Senjor E; Malarkannan S; Kos J; Jewett A
    Front Immunol; 2023; 14():1132807. PubMed ID: 37197660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes.
    Ko MW; Kaur K; Safaei T; Chen W; Sutanto C; Wong P; Jewett A
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.